ADMA also impairs the migratory capacity of angiogenic progenitor cells (APCs) in patients with coronary artery disease through a micro RNA-21-dependent mechanism, inhibiting superoxide dismutase 2 in APCs [18]. The gene discussed is SOD2; the disease is coronary artery disorder.